Cambrian BioPharma Inc — SEC Form 4 filings

SEC reporting owner CIK 1797409. 5 Form 4 filings on record with FilingPulse; latest filed 2026-06-01.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-06-13 to 2026-06-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sensei Biotherapeutics, Inc. (SNSE)10% owner510 legs · 52,907 sh · $787,8074

Form 4 filings — Cambrian BioPharma Inc

FiledFormIssuerReported transactionsSource
2026-06-014Sensei Biotherapeutics, Inc. (SNSE)Sale (S): 24,524 @ $20 · Sale (S): 476 @ $21.14EDGAR
2025-12-104Sensei Biotherapeutics, Inc. (SNSE)Sale (S): 3,105 @ $8.59 · Sale (S): 2,666 @ $7.95 · Option exercise (M): 395 @ $6.40 · Sale (S): 395 @ $8.04 · Sale (S): 446 @ $7.92 · Option exercise (M): 395 (derivative) @ $0EDGAR
2025-12-084Sensei Biotherapeutics, Inc. (SNSE)Sale (S): 5,000 @ $9.06 · Sale (S): 14,508 @ $11.40 · Sale (S): 1,745 @ $12.29 · Sale (S): 42 @ $13.16EDGAR
2025-05-234Sensei Biotherapeutics, Inc. (SNSE)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-06-134Sensei Biotherapeutics, Inc. (SNSE)Grant/award (A): 19,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797409 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →